Overall, various cancer cell lines consistently responded to combination inhibition of STAT3 signalling and Ref‐1 with additivity or synergy when compared to STAT3 inhibition alone, especially in pancreatic cancer cell lines. The gene discussed is STAT3; the disease is cancer.